$TNK Balance Sheet | Understand Stock

$TNK

$98.10 -$2.90 (2.87%) Close

$TNK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q4 FY2012 As of Dec 31, 2012	Q4 FY2011 As of Dec 31, 2011
ASSETS
Current
Cash and cash equivalents
Pool receivables from affiliates, net (note 16h)
Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Current
Restricted Cash - Current (note 16)
Marketable Securities, Current
Accounts receivable, net of allowance of $4.4 million (2024 - $5.3 million)
Interest receivable on investment in term loans (note 5)
Vessels held for sale (note 17)
Vessels held for sale (note 19)
Assets held for sale (note 19)
Assets held for sale (notes 15 and 22)
Due from affiliates (note 14c)
Due from affiliates, current
Current portion of derivative assets (note 9)
Bunker and lube oil inventory
Prepaid expenses
Investment in term loans (note 5)
Accrued revenue (note 4)
Other Assets, Current
Total current assets

At cost, less accumulated depreciation of $247.0 million (2010 - $203.8 million)
Loan to joint venture (note 6)
Restricted Cash - long-term (note 16)
At cost, less accumulated depreciation of $417.4 million (2019 - $437.1 million) (notes 9 and 19)
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets
Sale Leaseback Transaction, Accumulated Depreciation
At cost, less accumulated depreciation of $487.7 million (2024 - $570.9 million) (notes 9, 15 and 22)
Investment in term loans (note 5)
Loan to joint venture (note 5)
Vessels related to capital leases At cost, less accumulated depreciation of $111.3 million (2017 - $25.4 million) (notes 11 and 20)
Vessels related to finance leases, at cost, less accumulated depreciation of $nil (2023 - $92.4 million) (notes 10 and 15)
Operating lease right-of-use assets (notes 10 and 15)
Total vessels and equipment
Property plant and equipment including operating lease right of use assets
Investment in and advances to equity-accounted joint venture (note 6)
Derivative assets (note 13)
Derivative assets (note 9)
Intangible Assets, Net (Including Goodwill)
Other Assets, Noncurrent
Intangible assets at cost, less accumulated depreciation of $5.4 million (2023 - $5.0 million) (note 7)
Goodwill (note 7)
Total assets

Supplemental Balance Sheet Elements
Accounts Receivable, after Allowance for Credit Loss
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Sale Leaseback Transaction, Accumulated Depreciation
Accumulated amortization
LIABILITIES AND EQUITY
Current
Accounts payable
Accrued liabilities (notes 8 and 16)
Short-term debt (note 8)
Current portion of long-term debt (note 9)
Current portion of derivative instruments (note 9)
Current portion of derivative liabilities (note 11)
Current portion of in-process revenue contracts
Current obligation related to capital leases (note 11)
Deferred revenue
Current obligations related to finance leases (note 10)
Current portion of operating lease liabilities (note 10)
Due to affiliates (note 14c)
Liabilities associated with assets held for sale (note 19)
Other Current Liabilities
Total current liabilities

Long-term Debt, Excluding Current Maturities
Long-term obligation related to capital leases (note 11)
Long-term obligations related to finance leases (note 10)
Long-term operating lease liabilities (note 10)
Derivative liabilities (note 11)
Other long-term liabilities
Other long-term liabilities (notes 8, 16 and 18)
Total liabilities
Equity
Common stock and additional paid-in capital (300 million shares authorized, 71.1 million Class A and 12.5 million Class B shares issued and outstanding as of December 31, 2012 and 49.4 million Class A and 12.5 million Class B shares issued and outstanding as of December 31, 2011) (notes 3 and 13)
Accumulated Deficit
Common stock, shares authorized (in shares)
Class A
Common Class B
Total common stock, shares authorized (in shares)
Common Stock, Shares, Issued
Class A
Common Class B
Common Stock, Shares, Outstanding
Class A
Common Class B
Total common Stock, Shares, Outstanding

Common shares and paid-in capital (585.0 million shares authorized, 29.9 million Class A and 4.6 million Class B shares issued and outstanding as at December 31, 2025 and 585.0 million shares authorized, 29.7 million Class A and 4.6 million Class B shares issued and outstanding as at December 31, 2024) (note 13)
Accumulated surplus
Dropdown Predecessor equity (note 1)
Entities under Common Control equity (deficit)
Total equity

Total liabilities and equity

Comments